Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B—4 chronic kidney disease: A new direction of cardionephroprotection

Aim. To investigate the impact of anemia correction with erythropoiesis stimulants on the serum level of the circulating morphogenetic protein α-Klotho in patients with Stages 3B—4 chronic kidney disease (CKD). Subjects and methods. 64 patients aged 42±8 years with Stages 3B—4 nondiabetic CKD were e...

Full description

Bibliographic Details
Published in:	Терапевтический архив
Main Authors:	Yu S Milovanov, N A Mukhin, L V Kozlovskaya, S Yu Milovanova, M M Markina
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2016-06-01
Subjects:	chronic kidney disease anemia erythropoiesis stimulants circulating α-klotho
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/31977/pdf

Similar Items

Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease
by: L Iu Milovanova, et al.
Published: (2014-04-01)

Approaches to treating anemia in patients with malignancies. The 2007—2008 changes in Russian and International practice
by: N. V. Zhukov
Published: (2022-11-01)

Association between anemia and serum Klotho in middle-aged and older adults
by: Chencheng An, et al.
Published: (2023-02-01)

Administration of α-Klotho Does Not Rescue Renal Anemia in Mice
by: Min Young Park, et al.
Published: (2022-06-01)

Investigation of α-Klotho Concentrations in Serum of Cats Affected by Hypertrophic Cardiomyopathy
by: Stephan Neumann, et al.
Published: (2024-04-01)

Contemporary Practice of Anemia Treatment Among Dialysis Patients in the United States
by: Eric D. Weinhandl, et al.
Published: (2023-12-01)

The importance of whey protein levels of Klotho and fibroblast growth of factor-23 (fgf-23) as early diagnostic markers of chronic kidney damage
by: L. Yu. Milovanova, et al.
Published: (2014-06-01)

NSAID use may decrease serum Klotho levels
by: Jingchao Yan, et al.
Published: (2025-04-01)

Anemia of chronic diseases: the important aspects of pathogenesis and treatment
by: O. A. Rukavitsyn
Published: (2016-03-01)

EFFECT OF CHRONIC STRESS ON SERUM AND TISSUE LEVELS OF KLOTHO AND TNF-α
by: Mehmet Deniz Yener, et al.
Published: (2024-06-01)

Soluble αKlotho concentration in the inferior vena cava of patients with primary aldosteronism
by: Hodaka Yamada, et al.
Published: (2024-09-01)

Soluble αKlotho concentration in the inferior vena cava of patients with primary aldosteronism
by: Hodaka Yamada, et al.
Published: (2024-09-01)

Reduced Plasma Levels of α-Klotho and Their Correlation With Klotho Polymorphisms in Elderly Patients With Major Depressive Disorders
by: Xiang Gao, et al.
Published: (2021-10-01)

Association between serum cotinine and α-Klotho levels among adults: Findings from the National Health and Nutrition Examination Survey 2007–2016
by: Yu Yao, et al.
Published: (2022-06-01)

Circulating α-Klotho is Related to Plasma Aldosterone and Its Follow-Up Change Predicts CKD Progression
by: Jing Qian, et al.
Published: (2018-05-01)

Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective
by: Matti Aapro, et al.
Published: (2019-01-01)

Role of the intracerebroventricular injection α- klotho on food intake in broiler chicken: a novel study
by: Tahereh Eslam-aghdam, et al.
Published: (2024-11-01)

Anemia in cancer patients: addressing a neglected issue – diagnostics and therapeutic algorithm
by: Konrad Tałasiewicz, et al.
Published: (2023-10-01)

Current marijuana use is associated with lower circulating α-Klotho levels in US adults even after adjusting for tobacco use: A national cross-sectional analysis of NHANES
by: Kai Wei, et al.
Published: (2025-07-01)

Appropriate Use of Inpatient Erythropoiesis Stimulating Agents
by: Chenghao Cui, et al.
Published: (2024-11-01)

Association between testosterone and serum soluble α-klotho in U.S. males: a cross-sectional study
by: Zilong Zhang, et al.
Published: (2022-07-01)

Research progress on the biological role of serum soluble α-Klotho in chronic kidney diseases
by: SUN Long, et al.
Published: (2020-01-01)

Causal association between circulating α-Klotho levels and venous thromboembolism: a two-sample Mendelian randomization study
by: Yanmin Song, et al.
Published: (2025-01-01)

Beyond neurodegenerative diseases: α-synuclein in erythropoiesis
by: Ling Ling, et al.
Published: (2022-12-01)

The association between serum soluble α-Klotho and thyroid profile among adults from NHANES 2007–2012
by: Jing Dong, et al.
Published: (2024-08-01)

The Role of Soluble α-klotho Protein in Acromegaly
by: Oana PINZARIU, et al.
Published: (2023-03-01)

α-klotho reduces susceptibility to osteoarthritis: evidence from cross-sectional studies and Mendelian randomization
by: Zhao Li, et al.
Published: (2024-11-01)

Quantitative systems pharmacology model of erythropoiesis to simulate therapies targeting anemia due to chronic kidney disease
by: Mrittika Roy, et al.
Published: (2023-12-01)

Hepcidin and Anemia: A Tight Relationship
by: Alessia Pagani, et al.
Published: (2019-10-01)

Role of alpha and gamma Klotho genes in the development of differentiated thyroid carcinoma on top of goiter
by: El-Saeed Wesam S., et al.
Published: (2023-09-01)

Sex differences in the association between serum α-Klotho levels and hyperlipidemia: a cross-sectional study from NHANES 2013–2016
by: Yu Han, et al.
Published: (2025-02-01)

Usefulness of mid-week hemoglobin measurement for anemia management in patients undergoing hemodialysis: a retrospective cohort study
by: Soo Ya Bae, et al.
Published: (2019-08-01)

Association between plasma trans fatty acids and serum α-klotho levels in adults in the United States of America: an analysis of the NHANES 2009–2010 datasets
by: Yali Liang, et al.
Published: (2024-08-01)

Role of circulating endothelial progenitors in responsiveness to erythropoiesis-stimulating agents in hemodialysis patients
by: Akira Ishimitsu, et al.
Published: (2021-10-01)

Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis
by: Geo Neul Park, et al.
Published: (2024-05-01)

Central adiposity and α-klotho: inflammatory mechanisms underlying aging biomarkers related to body roundness index
by: Rui Du, et al.
Published: (2025-04-01)

α-klotho as a biomarker of amyloid β levels in the cerebrospinal fluid
by: Jacob Raber, et al.
Published: (2025-06-01)

Association between α-klotho levels and adults with COPD in the United States
by: Dan Yan
Published: (2024-07-01)

COST-MINIMIZATION ANALYSIS OF USING SHORT AND LONG-ACTING ERYTHROPOESIS-STIMULATING AGENTS FOR CORRECTION OF NEPHROGENIC ANEMIA AGAINST THE BACKGROUND OF SUBSTITUTION THERAPY
by: I. S. Krysanov, et al.
Published: (2021-10-01)

Biomarkers of erythropoiesis response to intravenous iron in a crossover pilot study in unexplained anemia of the elderly
by: Justin J. Yoo, et al.
Published: (2023-12-01)